BIO-key posts audited 2025 net loss of $7.16 million in Form 10-K/A filing
BIO-key International, Inc. BKYI | 0.00 |
- BIO-key International filed an amended annual report with audited 2025 results, replacing the auditor’s report and consent.
- Net loss widened to USD 7.16 million from USD 4.3 million; revenue fell to USD 5.94 million from USD 6.93 million.
- Recorded a USD 2.5 million impairment on its Boumarang investment, cutting the carrying value to USD 2.5 million.
- Cash and cash equivalents rose to USD 2.69 million from USD 437,604; operating cash outflow was USD 4.67 million.
- Auditor flagged substantial doubt about going concern; shares trade on OTC Markets following a Nasdaq trading suspension on May 13, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-020535), on June 15, 2026, and is solely responsible for the information contained therein.
